CD147 induces asthmatic airway remodeling and activation of circulating fibrocytes in a mouse model of asthma

Abstract

OVA-triggered airway inflammation and airway remodeling in asthmatic mice can be repressed by anti-CD147 treatment, along with inhibiting the accumulation and activation of circulating fibrocytes.